PMAM
IMMU

Picton Mahoney Asset Management’s Immunomedics Inc IMMU Stock Holding History

Picton Mahoney Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-175,000
Closed -$14.9M – 488
2020
Q3 		$14.9M Buy
+175,000
New +$8.85M 0.82% 28

Picton Mahoney Asset Management's IMMU Position: Q4 2020 in Review

Picton Mahoney Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 175,000 shares — an estimated $14.9M sold.

Picton Mahoney Asset Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $14.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Picton Mahoney Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 175,000 Immunomedics Inc shares in Q4 2020, an estimated $14.9M.
  • Picton Mahoney Asset Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Immunomedics Inc position peaked at $14.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.